Today: 13 June 2026
IBM stock today: Shares slip to $291.50 as 2026 begins — what investors watch next
3 January 2026
2 mins read

IBM stock today: Shares slip to $291.50 as 2026 begins — what investors watch next

NEW YORK, January 3, 2026, 13:53 ET — Market closed

  • IBM ended Friday at $291.50, down about 1.7%, with U.S. markets closed Saturday.
  • A Form 4 filing showed a director deferred board fees into 338 “Promised Fee Shares” tied to IBM stock.
  • Focus turns to next week’s U.S. jobs and inflation reports, and IBM’s Jan. 28 earnings announcement.

International Business Machines Corp (NYSE: IBM) shares closed down about 1.7% at $291.50 on Friday, after trading between $289.27 and $298.33, market data showed. About 4.7 million shares changed hands.

The decline matters as investors reset positions for the first full week of 2026, with January data and corporate results expected to drive expectations for interest rates and enterprise tech spending.

IBM is also coming off a strong year. Zacks Investment Research said IBM has surged about 33% over the past 12 months, helped by demand tied to hybrid cloud and artificial intelligence offerings.

Wall Street’s tone has been choppy. On Friday, the Dow and S&P 500 ended higher while the Nasdaq was little changed, helped by a rally in chipmakers, Reuters reported. Joe Mazzola, head of trading and derivatives strategist at Charles Schwab, said the market is seeing a “buy the dip, sell the rip” mentality — buying pullbacks and selling into rallies. Reuters

IBM itself had little fresh headline news on Friday, but a regulatory filing showed director Peter R. Voser deferred board fees into 338 “Promised Fee Shares” dated Dec. 31. SEC

Promised Fee Shares are a deferred-compensation award tied to IBM common stock. The units pay out after retirement in stock or cash, the filing said.

The stock has now fallen for three straight sessions and sits about 10% below its 52-week high of $324.90, according to MarketWatch data. IBM outperformed Microsoft on Friday but lagged Alphabet’s shares.

For investors, the near-term focus is whether IBM can keep delivering steady software performance while consulting demand holds up as clients scrutinize budgets.

Macro data could do as much as company headlines to steer the next leg. The Employment Situation report for December is scheduled for Jan. 9, followed by the Consumer Price Index report for December on Jan. 13, the U.S. Bureau of Labor Statistics calendar shows.

A Reuters “Week Ahead” column said investors are also bracing for a packed January that includes fourth-quarter earnings season and policy risk around tariffs and the Federal Reserve’s outlook after a strong 2025 that left valuations elevated. Reuters

For IBM, the next clear company catalyst is earnings. IBM has scheduled its fourth-quarter 2025 earnings announcement for Jan. 28 (preliminary date), according to its investor events page.

Before the next session on Monday, traders will watch whether IBM can hold the $290 area after Friday’s session low and whether early-January flows continue to favor industrial and value shares over mega-cap tech.

Any upside surprise in jobs or inflation next week would likely lift Treasury yields and pressure stock valuations, while softer readings would reinforce bets on rate cuts later in 2026.

On Jan. 28, investors will focus on IBM’s 2026 outlook, including commentary on software growth, consulting signings (new contract bookings) and cash generation — the metrics that typically move the stock after results.

Stock Market Today

  • Axon Enterprise Stock Review: Valuation and Recent Price Volatility
    June 13, 2026, 1:39 AM EDT. Axon Enterprise (AXON) closed at $441.73 amid share price volatility, declining 1.0% in 1 day and 9.13% over 7 days, despite a 30-day gain of 17.23%. The 1-year shareholder return stands at a 43.41% decline. Analysts suggest a fair value estimate of $606.83, indicating the stock may be undervalued by 27.2%. Axon's shift from hardware to a software and data platform for public safety underpins growth potential. However, the stock trades at a rich price-to-sales (P/S) ratio of 11.9x, compared to the aerospace/defense industry average of 5.6x, reflecting valuation risks if market sentiment shifts or budget constraints arise. Investors should weigh Axon's long-term platform economics against potential headwinds in public sector spending and competitive pressures.

Latest articles

SGH Limited Holds Back as ASX 200 Pushes Higher Before FY26 Results

SGH Limited Holds Back as ASX 200 Pushes Higher Before FY26 Results

13 June 2026
SGH closed at A$41.51, up 0.70% but underperformed the S&P/ASX 200’s 1.98% surge, as investors weighed solid cash flow and Boral margin gains against a high 36.03 P/E, mixed demand, and M&A risk; the next key catalyst is FY26 results on August 11, with analysts’ average target at A$47.64, 14.76% above Friday’s close.
NCR Voyix Rallies 10% After Investors Shift on Turnaround Bets

NCR Voyix Rallies 10% After Investors Shift on Turnaround Bets

13 June 2026
NCR Voyix soared 10.25% to $7.85, far outpacing the market, as investors focus on the company’s 2026 cash-flow and earnings targets; the next key catalyst is the Q2 2026 earnings update, with stock valuation appearing low if management delivers on margin and cash-flow goals, but risks remain with declining reported revenue and high debt.
Defense and space stocks jump to start 2026 as Boeing, Rocket Lab lead gains
Previous Story

Defense and space stocks jump to start 2026 as Boeing, Rocket Lab lead gains

Pfizer stock today: PFE ends first 2026 session higher as pricing scrutiny returns and Feb. 3 results loom
Next Story

Pfizer stock today: PFE ends first 2026 session higher as pricing scrutiny returns and Feb. 3 results loom

Go toTop